Pharmaceutical supply chains produce and deliver the drugs that enter your body. If anything goes wrong at any stage of production or distribution, it can result in patient disablement, or even death. That was evidenced in late 2007, when reports of unexpected allergic-type reactions in patients undergoing dialysis began to land on regulatory authority desks. Investigation revealed that the blood thinning agent, heparin, was the culprit. The manufacturer...